Icon

ZYMAXID (nda022548)- (0.5%)

GATIFLOXACIN ABBVIE
0.5%
Yes No
2020-Feb-20 Expired
None 2013-May-18
None No
ZYMAXID® is a quinolone antimicrobial indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Haemophilus influenzae, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mitis group, Streptococcus oralis, Streptococcus pneumoniae
4 0 4
Total Other Developers 4
Drugs with Suitability No
0.5% ** ** - - 1
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** *** ***** ******* *********** ****-*, **** **. *-* *** *-*-*, ******* ******** **** ***** **, ****. ****, ******* ****, ****. ****, *********, ****** ******* ******, ***** (***) ***
****** ***** ***** ********* ******* *** (*** *****) *********** *** ******* ******, **********, *** **** (**) *****, ****** ****** (***) ***
****** ****** ***** ******** *** *********** **** ***** *******, **** *****, ***** (**) *****, ****** ****** (***) ***
****** ******* ****** ******** ******* *********** ****** **.*** & ***. ******************, **************** (****), *********** (********), *************, ***** **** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.